| Supplementary Protection Certificate (SPC) Summary | |||||||||||||||
| SPC No. | 2007/064 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date of filing | 18/12/2007 | ||||||||||||||
| Notification of Application Published | 23/01/2008 | ||||||||||||||
| Status | Expired | ||||||||||||||
| Notification of Grant Published | 09/10/2013 | ||||||||||||||
| Date of Expiry of SPC | 02/09/2018 | ||||||||||||||
| Applicant |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES The National Institute of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 Rockville, MD 20852 UNITED STATES OF AMERICA |
||||||||||||||
| Patent Number | 0662132 | ||||||||||||||
| Title of Invention | SELF-ASSEMBLING RECOMBINANT HPV16 PAPILLOMAVIRUS CAPSID PROTEINS | ||||||||||||||
| Date of Expiry of Patent | 02/09/2013 | ||||||||||||||
| Product Type | Medicinal Product | ||||||||||||||
| Product Identity | Human papillomavirus type 16 L1 virus-like particles made from insect cells | Market Authorisation | Ireland | European Union | |||||||||||
| Authorisation No | EU/1/07/419/001-009 | EU/1/07/419/001-009 | |||||||||||||
| Authorisation Date | 20/09/2007 | 20/09/2007 | |||||||||||||
| Identity of Product Authorised | Cervarix - Human Papilloma Virus 16 and Human Papilloma Virus 18 L1 proteins | ||||||||||||||
| Address for Service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||||||||
| Renewal Fees |
|
||||||||||||||
| 02/10/2018 | SPC expired on 02/09/2018. | ||||||||||||||